Table 1.
Demographic and clinical variables in study sample
| PBT | Control group | Significance (P) | |
|---|---|---|---|
| Gender, n (%) | |||
| Male | 32 (61.53) | 30 (57.69) | 0.689 |
| Female | 20 (38.46) | 22 (42.30) | |
| Characteristic, mean (SD) | |||
| Age | 38.17 (14.06) | 39.54 (14.36) | 0.592 |
| EORTC QOL | 28.02 (5.267) | 21.88 (2.533) | <0.001* |
| GHQ-12 | 2.04 (2.737) | 0.50 (1.820) | 0.000 |
| HADS | 7.56 (7.627) | 3.96 (4.794) | 0.024* |
| MMSE | 25.62 (2.198) | 28.92 (2.936) | <0.001* |
*P<0.05 was considered statistically significant. Chi-square test was used for gender, Mann–Whitney test for HADS and 12-item GHQ. PBT – Primary brain tumor; EORTC QOL – European Organization for Research and Treatment of Cancer quality of life scores; GHQ-12 – 12-item General Health Questionnaire scores; HADS – Hospital Anxiety and Depression Scale scores; MMSE – Mini-Mental State Examination scores; SD – Standard deviation